Biomarker detection for benign breast diseases and primary breast cancer by serum and tissue protein profiling. - Breast Cancer Proteomics study (BCP study)

Slotervaartziekenhuis0 个研究点目标入组 380 人开始时间: 待定最近更新: 2024年5月13日

适应症

试验速览

暂无简介。

•1. Female patients diagnosed with benign breast disease or primary breast cancer (that will be treated surgically) by breast biopsy at the Department of Surgery of the Slotervaart Hospital in Amsterdam.
•2. Female patients diagnosed with benign breast disease and treated surgically the Department of Surgery of the Slotervaart Hospital in Amsterdam.
•3. Female patients undergoing breast reduction surgery at the Department of Plastic Surgery of the Slotervaart Hospital in Amsterdam.
•4. Age > 18yrs.
•5. Able and willing to undergo blood and tissue sampling for protein analysis.

•1. Known history of (treated) malignancies.
•2. Incapacity of participant to give written informed consent.
•3. Patients not able to undergo blood and tissue sampling for protein analysis.
•4. Any psychological, familial, sociological or geographical condition that may potentially interfere with compliance to the study protocol.

发起方

Slotervaartziekenhuis